Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2

被引:0
|
作者
Josef Miethe
Claudia Schwartz
Katja Wottrich
Dorit Wenning
Karl-Heinz Klempnauer
机构
[1] Institut für Biochemie,
[2] Westfälische-Wilhelms-Universität Münster,undefined
来源
Oncogene | 2001年 / 20卷
关键词
Myc; ATF2; phosphorylation; protein turnover;
D O I
暂无
中图分类号
学科分类号
摘要
Myc is a key regulator of cell growth, differentiation and apoptosis, and affects cell fate decisions by activating as well as by inhibiting the expression of cellular genes. Myc is a member of the basic region–helix–loop–helix–leucine zipper (b-HLH-Zip) class of transcription factors, which heterodimerizes with the Max protein and recognizes a consensus Myc binding motif. Stimulation of gene expression by Myc is thought to be mediated by direct binding of Myc–Max heterodimers to specific target genes. So far, only a few genes have been identified as direct binding targets of Myc, raising the possibility that Myc affects gene expression also by indirect mechanisms. In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity. Taken together, our results suggest that v-Myc can affect gene expression indirectly by modulating the activity of ATF2.
引用
收藏
页码:8116 / 8124
页数:8
相关论文
共 50 条
  • [1] Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2
    Miethe, J
    Schwartz, C
    Wottrich, K
    Wenning, D
    Klempnauer, KH
    ONCOGENE, 2001, 20 (56) : 8116 - 8124
  • [2] The roles of ATF2 (activating transcription factor 2) in tumorigenesis
    Gozdecka, Malgorzata
    Breitwieser, Wolfgang
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 230 - 234
  • [3] Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation
    Fuchs, SY
    Tappin, I
    Ronai, Z
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) : 12560 - 12564
  • [4] Suppressor role of activating transcription factor 2 (ATF2) in skin cancer
    Bhoumik, Anindita
    Fichtman, Boris
    DeRossi, Charles
    Breitwieser, Wolfgang
    Kluger, Harriet M.
    Davis, Sean
    Subtil, Antonio
    Meltzer, Paul
    Krajewski, Stan
    Jones, Nic
    Ronai, Ze'ev
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) : 1674 - 1679
  • [5] Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2)
    Steinmüller, L
    Thiel, G
    BIOLOGICAL CHEMISTRY, 2003, 384 (04) : 667 - 672
  • [6] ATF2 on the double - activating transcription factor and DNA damage response protein
    Bhoumik, Anindita
    Lopez-Bergami, Pablo
    Ronai, Ze'ev
    PIGMENT CELL RESEARCH, 2007, 20 (06): : 498 - 506
  • [7] ACTIVATING TRANSCRIPTION FACTOR ATF2 NEGATIVELY REGULATES THE EXPRESSION OF ENDOTHELIAL NOTCH LIGANDS
    Olivares, Ivonne
    Kalyanakrishnan, Krithika
    Ahmed, Suhail
    Murcott, Clare
    Wilkinson, Robert N.
    Cotton, James
    Breitwieser, Wolfgang
    Morris, Mark R.
    Armesilla, Angel L.
    HEART, 2019, 105 : A167 - A168
  • [8] ATF2 phosphorylation: A novel aspect of insulin signaling
    Baan, B
    Maassen, JA
    Ouwens, DM
    DIABETES, 2003, 52 : A304 - A304
  • [9] Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9 - Implications of the ubiquitin/proteasome pathway in regulation of ATF2 in T class
    Firestein, R
    Feuerstein, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) : 5892 - 5902
  • [10] Two-step activation of transcription factor ATF2 by insulin
    Ouwens, DM
    Van Der Zon, G
    Maasen, JA
    DIABETES, 2002, 51 : A323 - A323